Website Header with Language Selector and Dropdowns

Tepotinib is a selective MET tyrosine kinase inhibitor that blocks signaling pathways involved in tumor cell growth and survival. It is used in the treatment of non-small cell lung cancer with MET exon 14 skipping alterations. By inhibiting MET, it disrupts oncogenic signaling and helps reduce tumor progression.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Tepotinib and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Tepotinib impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Tepotinib-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.

CAT No: CL-TPNB-01
CAS No: 1100598-32-0
Mol Wt: 492.6
Mol F: C29H28N6O2
Inv Status:Custom Synthesis
CAT No: CL-TPNB-02
CAS No: NA
Mol Wt: 506.6
Mol F: C29H26N6O3
Inv Status:Custom Synthesis
CAT No: CL-TPNB-03
CAS No: 1100598-47-7
Mol Wt: 427.5
Mol F: C23H29N3O5
Inv Status:Custom Synthesis
CAT No: CL-TPNB-04
CAS No: 1103506-77-9
Mol Wt: 444.3
Mol F: C22H14BrN5O
Inv Status:Custom Synthesis
CAT No: CL-TPNB-05
CAS No: 1103506-79-1
Mol Wt: 381.4
Mol F: C22H15N5O2
Inv Status:Custom Synthesis
CAT No: CL-TPNB-06
CAS No: 1103506-80-4
Mol Wt: 578.7
Mol F: C33H34N6O4
Inv Status:Custom Synthesis
Address(India):

Plot No. A-737/2, TTC Industrial area,
MIDC, Kopar Khairne, Navi Mumbai, INDIA, 400710

           
Address(Bangladesh):

House No. - 12, Road No. - 17, Nikunja -2,
Khilkhet, Dhaka-1230, Bangladesh.

Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.